Compare $KPTI vs $SYBX | Chartloom

Compare

$KPTI vs $SYBX

Karyopharm Therapeutics Inc · Synlogic Inc

KPTI

Karyopharm Therapeutics Inc

SYBX

Synlogic Inc

Compare $KPTI vs $SYBX

Comparing Karyopharm Therapeutics Inc and Synlogic Inc

KPTIKaryopharm Therapeutics Inc

SYBXSynlogic Inc

KPTIKaryopharm Therapeutics Inc

Market cap

$14M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

0.10x

Rev growth (TTM)

6.8%

YTD performance

-91.6%

52W performance

-89.7%

FCF yield

-476.7%

SYBXSynlogic Inc

Market cap

$13M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-6.0%

52W performance

-24.7%

FCF yield

-28.5%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

KPTI

SYBX

Detailed metrics comparison

KPTI

Karyopharm Therapeutics Inc

SYBX

Synlogic Inc

Market Cap

KPTI$14M

SYBX$13M

Enterprise Value

KPTI$281M

SYBX$292K

Price

KPTI$0.61

SYBX$1.10

P/E Ratio

KPTIN/A

SYBXN/A

P/S Ratio

KPTI0.09x

SYBX4.20x

EV/Sales

KPTI1.92x

SYBX0.09x

EV/EBITDA

KPTI0.00x

SYBX0.00x

P/B Ratio

KPTI0.36x

SYBX1.12x

P/FCF Ratio

KPTIN/A

SYBXN/A

EV/FCF

KPTI-4.30x

SYBX-0.08x

PEG Ratio

KPTIN/A

SYBXN/A

Forward P/E (NTM)

KPTIN/A

SYBXN/A

Forward P/S (NTM)

KPTI0.10x

SYBXN/A

Revenue (TTM)

KPTI$147M

SYBX$0

Revenue Growth (YoY)

KPTI6.8%

SYBXN/A

Forward Rev Growth

KPTI27.7%

SYBX0.0%

Gross Margin (TTM)

KPTI95.9%

SYBX0.0%

Operating Margin (TTM)

KPTI0.0%

SYBX0.0%

EBITDA Margin (TTM)

KPTI-56.1%

SYBX0.0%

Net Margin (TTM)

KPTI-153.3%

SYBX0.0%

FCF Margin (TTM)

KPTI-44.6%

SYBXN/A

Net Income (TTM)

KPTI$-225M

SYBX$-655K

FCF (TTM)

KPTI$-65M

SYBX$-4M

EPS (TTM)

KPTI-$7.77

SYBX-$0.05

ROE (TTM)

KPTI-18243.0%

SYBX-560.0%

ROA (TTM)

KPTI-20094.0%

SYBX-436.0%

ROIC (TTM)

KPTI-6632.0%

SYBX-560.0%

Cash

KPTI$55M

SYBX$13M

Debt

KPTI$322M

SYBX$0

Net Cash/Debt

KPTI$-267M

SYBX$13M

Current Ratio (TTM)

KPTI0.79x

SYBX9.19x

Quick Ratio (TTM)

KPTI0.71x

SYBX9.05x

Debt/Equity (TTM)

KPTI3.78x

SYBX0.00x

Debt/Assets (TTM)

KPTI0.0%

SYBX0.0%

Interest Coverage (TTM)

KPTIN/A

SYBXN/A

Net Debt/EBITDA (TTM)

KPTI0.00x

SYBX0.00x

Beta

KPTI1.14

SYBX0.87

52W Performance

KPTI-89.7%

SYBX-24.7%

YTD Performance

KPTI-91.6%

SYBX-6.0%

% from 52W High

KPTI-94.5%

SYBX-41.2%

% from 52W Low

KPTI7.1%

SYBX103.7%

Asset Turnover (TTM)

KPTI1.31x

SYBX0.05x

FCF Yield (TTM)

KPTI-476.7%

SYBX-28.5%

Earnings Yield (TTM)

KPTI-1639.3%

SYBX-4.9%

Dividend Yield (TTM)

KPTIN/A

SYBXN/A

Rule of 40

KPTI-37.8

SYBX0.0

EV/GP/RG

KPTI0.07

SYBXN/A

Ticker research

View KPTI research View SYBX research

Metric	KPTI Karyopharm Therapeutics Inc	SYBX Synlogic Inc
Market & Valuation
Market Cap	$14M	$13M
Enterprise Value	$281M	$292K
Price	$0.61	$1.10
P/E Ratio	N/A	N/A
P/S Ratio	0.09x	4.20x
EV/Sales	1.92x	0.09x
EV/EBITDA	0.00x	0.00x
P/B Ratio	0.36x	1.12x
P/FCF Ratio	N/A	N/A
EV/FCF	-4.30x	-0.08x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	0.10x	N/A
Revenue & Growth
Revenue (TTM)	$147M	$0
Revenue Growth (YoY)	6.8%	N/A
Forward Rev Growth	27.7%	0.0%
Profitability
Gross Margin (TTM)	95.9%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-56.1%	0.0%
Net Margin (TTM)	-153.3%	0.0%
FCF Margin (TTM)	-44.6%	N/A
Net Income (TTM)	$-225M	$-655K
FCF (TTM)	$-65M	$-4M
EPS (TTM)	-$7.77	-$0.05
ROE (TTM)	-18243.0%	-560.0%
ROA (TTM)	-20094.0%	-436.0%
ROIC (TTM)	-6632.0%	-560.0%
Financial Health
Cash	$55M	$13M
Debt	$322M	$0
Net Cash/Debt	$-267M	$13M
Current Ratio (TTM)	0.79x	9.19x
Quick Ratio (TTM)	0.71x	9.05x
Debt/Equity (TTM)	3.78x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.14	0.87
52W Performance	-89.7%	-24.7%
YTD Performance	-91.6%	-6.0%
% from 52W High	-94.5%	-41.2%
% from 52W Low	7.1%	103.7%
Efficiency & Yields
Asset Turnover (TTM)	1.31x	0.05x
FCF Yield (TTM)	-476.7%	-28.5%
Earnings Yield (TTM)	-1639.3%	-4.9%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-37.8	0.0
EV/GP/RG	0.07	N/A
Ticker research	View KPTI research	View SYBX research

Valuation

P/S Ratio

KPTI

0.09x

SYBX

4.20x

EV/FCF

KPTI

-4.30x

SYBX

-0.08x

Growth & revenue

Revenue Growth TTM

KPTI

6.8%

Forward Revenue Growth

KPTI

27.7%

SYBX

0.0%

Profitability & performance

Gross Margin

KPTI

95.9%

SYBX

0.0%

ROE

SYBX

-560.0%

KPTI

-18243.0%

FCF Yield %

SYBX

-28.5%

KPTI

-476.7%

52-Week Performance

SYBX

-24.7%

KPTI

-89.7%

Detailed metrics comparison

KPTI

Karyopharm Therapeutics Inc

SYBX

Synlogic Inc

Market Cap

KPTI$14M

SYBX$13M

Enterprise Value

KPTI$281M

SYBX$292K

Price

KPTI$0.61

SYBX$1.10

P/E Ratio

KPTIN/A

SYBXN/A

P/S Ratio

KPTI0.09x

SYBX4.20x

EV/Sales

KPTI1.92x

SYBX0.09x

EV/EBITDA

KPTI0.00x

SYBX0.00x

P/B Ratio

KPTI0.36x

SYBX1.12x

P/FCF Ratio

KPTIN/A

SYBXN/A

EV/FCF

KPTI-4.30x

SYBX-0.08x

PEG Ratio

KPTIN/A

SYBXN/A

Forward P/E (NTM)

KPTIN/A

SYBXN/A

Forward P/S (NTM)

KPTI0.10x

SYBXN/A

Revenue (TTM)

KPTI$147M

SYBX$0

Revenue Growth (YoY)

KPTI6.8%

SYBXN/A

Forward Rev Growth

KPTI27.7%

SYBX0.0%

Gross Margin (TTM)

KPTI95.9%

SYBX0.0%

Operating Margin (TTM)

KPTI0.0%

SYBX0.0%

EBITDA Margin (TTM)

KPTI-56.1%

SYBX0.0%

Net Margin (TTM)

KPTI-153.3%

SYBX0.0%

FCF Margin (TTM)

KPTI-44.6%

SYBXN/A

Net Income (TTM)

KPTI$-225M

SYBX$-655K

FCF (TTM)

KPTI$-65M

SYBX$-4M

EPS (TTM)

KPTI-$7.77

SYBX-$0.05

ROE (TTM)

KPTI-18243.0%

SYBX-560.0%

ROA (TTM)

KPTI-20094.0%

SYBX-436.0%

ROIC (TTM)

KPTI-6632.0%

SYBX-560.0%

Cash

KPTI$55M

SYBX$13M

Debt

KPTI$322M

SYBX$0

Net Cash/Debt

KPTI$-267M

SYBX$13M

Current Ratio (TTM)

KPTI0.79x

SYBX9.19x

Quick Ratio (TTM)

KPTI0.71x

SYBX9.05x

Debt/Equity (TTM)

KPTI3.78x

SYBX0.00x

Debt/Assets (TTM)

KPTI0.0%

SYBX0.0%

Interest Coverage (TTM)

KPTIN/A

SYBXN/A

Net Debt/EBITDA (TTM)

KPTI0.00x

SYBX0.00x

Beta

KPTI1.14

SYBX0.87

52W Performance

KPTI-89.7%

SYBX-24.7%

YTD Performance

KPTI-91.6%

SYBX-6.0%

% from 52W High

KPTI-94.5%

SYBX-41.2%

% from 52W Low

KPTI7.1%

SYBX103.7%

Asset Turnover (TTM)

KPTI1.31x

SYBX0.05x

FCF Yield (TTM)

KPTI-476.7%

SYBX-28.5%

Earnings Yield (TTM)

KPTI-1639.3%

SYBX-4.9%

Dividend Yield (TTM)

KPTIN/A

SYBXN/A

Rule of 40

KPTI-37.8

SYBX0.0

EV/GP/RG

KPTI0.07

SYBXN/A

Ticker research

View KPTI research View SYBX research

Metric	KPTI Karyopharm Therapeutics Inc	SYBX Synlogic Inc
Market & Valuation
Market Cap	$14M	$13M
Enterprise Value	$281M	$292K
Price	$0.61	$1.10
P/E Ratio	N/A	N/A
P/S Ratio	0.09x	4.20x
EV/Sales	1.92x	0.09x
EV/EBITDA	0.00x	0.00x
P/B Ratio	0.36x	1.12x
P/FCF Ratio	N/A	N/A
EV/FCF	-4.30x	-0.08x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	0.10x	N/A
Revenue & Growth
Revenue (TTM)	$147M	$0
Revenue Growth (YoY)	6.8%	N/A
Forward Rev Growth	27.7%	0.0%
Profitability
Gross Margin (TTM)	95.9%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-56.1%	0.0%
Net Margin (TTM)	-153.3%	0.0%
FCF Margin (TTM)	-44.6%	N/A
Net Income (TTM)	$-225M	$-655K
FCF (TTM)	$-65M	$-4M
EPS (TTM)	-$7.77	-$0.05
ROE (TTM)	-18243.0%	-560.0%
ROA (TTM)	-20094.0%	-436.0%
ROIC (TTM)	-6632.0%	-560.0%
Financial Health
Cash	$55M	$13M
Debt	$322M	$0
Net Cash/Debt	$-267M	$13M
Current Ratio (TTM)	0.79x	9.19x
Quick Ratio (TTM)	0.71x	9.05x
Debt/Equity (TTM)	3.78x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.14	0.87
52W Performance	-89.7%	-24.7%
YTD Performance	-91.6%	-6.0%
% from 52W High	-94.5%	-41.2%
% from 52W Low	7.1%	103.7%
Efficiency & Yields
Asset Turnover (TTM)	1.31x	0.05x
FCF Yield (TTM)	-476.7%	-28.5%
Earnings Yield (TTM)	-1639.3%	-4.9%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-37.8	0.0
EV/GP/RG	0.07	N/A
Ticker research	View KPTI research	View SYBX research